159 related articles for article (PubMed ID: 37858628)
1. Boron in cancer therapeutics: An overview.
Kulkarni S; Bhandary D; Singh Y; Monga V; Thareja S
Pharmacol Ther; 2023 Nov; 251():108548. PubMed ID: 37858628
[TBL] [Abstract][Full Text] [Related]
2. Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment.
Coghi P; Li J; Hosmane NS; Zhu Y
Med Res Rev; 2023 Sep; 43(5):1809-1830. PubMed ID: 37102375
[TBL] [Abstract][Full Text] [Related]
3. The synthesis and use of boronated amino acids for boron neutron capture therapy.
Kabalka GW; Yao ML
Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
[TBL] [Abstract][Full Text] [Related]
4. Boron delivery agents for neutron capture therapy of cancer.
Barth RF; Mi P; Yang W
Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
[TBL] [Abstract][Full Text] [Related]
5. Boronated DNA-binding compounds as potential agents for boron neutron capture therapy.
Crossley EL; Ziolkowski EJ; Coderre JA; Rendina LM
Mini Rev Med Chem; 2007 Mar; 7(3):303-13. PubMed ID: 17346220
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of boronated unnatural amino acids as new boron carriers.
Kabalka GW; Yao ML; Marepally SR; Chandra S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S374-9. PubMed ID: 19398346
[TBL] [Abstract][Full Text] [Related]
7. YC-1 sensitizes the antitumor effects of boron neutron capture therapy in hypoxic tumor cells.
Harada T; Hirose K; Wada Y; Sato M; Ichise K; Aoki M; Kato T; Takeda K; Takai Y
J Radiat Res; 2020 Jul; 61(4):524-534. PubMed ID: 32367141
[TBL] [Abstract][Full Text] [Related]
8. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
[TBL] [Abstract][Full Text] [Related]
9. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
10. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
[TBL] [Abstract][Full Text] [Related]
11. Boronated compounds for imaging guided BNCT applications.
Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy.
Sjöberg S; Carlsson J; Ghaneolhosseini H; Gedda L; Hartman T; Malmquist J; Naeslund C; Olsson P; Tjarks W
J Neurooncol; 1997 May; 33(1-2):41-52. PubMed ID: 9151222
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Boron Compound Concentration for BNCT Using Positron Emission Tomography.
Balcerzyk M; De-Miguel M; Guerrero C; Fernandez B
Cells; 2020 Sep; 9(9):. PubMed ID: 32932575
[No Abstract] [Full Text] [Related]
14. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
15. A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma.
Xiang J; Ma L; Gu Z; Jin H; Zhai H; Tong J; Liang T; Li J; Ren Q; Liu Q
Cells; 2022 Mar; 11(7):. PubMed ID: 35406737
[TBL] [Abstract][Full Text] [Related]
16. Boronated thymidine analogues for boron neutron capture therapy.
Thirumamagal BT; Johnsamuel J; Cosquer GY; Byun Y; Yan J; Narayanasamy S; Tjarks W; Barth RF; Al-Madhoun AS; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):861-6. PubMed ID: 16901817
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT.
Seneviratne DS; Saifi O; Mackeyev Y; Malouff T; Krishnan S
Cells; 2023 May; 12(10):. PubMed ID: 37408232
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
19. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
Yinghuai Z; Hosmane NS
Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
[TBL] [Abstract][Full Text] [Related]
20. Electroporation optimizes the uptake of boron-10 by tumor for boron neutron capture therapy (BNCT) mediated by GB-10: a boron biodistribution study in the hamster cheek pouch oral cancer model.
Garabalino MA; Olaiz N; Portu A; Saint Martin G; Thorp SI; Pozzi ECC; Curotto P; Itoiz ME; Monti Hughes A; Colombo LL; Nigg DW; Trivillin VA; Marshall G; Schwint AE
Radiat Environ Biophys; 2019 Aug; 58(3):455-467. PubMed ID: 31123853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]